More than 250 novel coronavirus pneumonia projects overseas are being reviewed.

Wen Yiling For months after the epidemic besieged the city of Wuhan, there was still a steady stream of "blood transfusion" to Hubei With the outbreak becoming more and more serious, scientists around the world are looking forward to finding the most suitable "life-saving medicine" The soul torture of "when can it appear" is the pressure that the medical circle has to bear Novel coronavirus was searched on the website of China clinical trial registration website as of 16, and 85 items of intervention research were retrieved 25 searches were conducted on the "2019-nCov" search on ClinicalTrials.Gov An endless stream of drugs has become the dawn of epidemic treatment in Wuhan Meibo healthcare, which links Chinese and overseas healthcare innovation and is committed to providing docking services between Chinese resources and overseas innovation projects, also responded immediately a week ago and joined the ranks of the search for drugs Novel coronavirus pneumonia was launched in February 10th, and new overseas crown fever treatment, vaccine and diagnostic technologies were collected overseas By the end of June 16, more than 250 overseas projects had been received by mabujian, which intended to cooperate with domestic scientific research institutions and enterprises, including products in different fields such as drugs, vaccines, diagnosis, devices, etc the mechanism of drug action includes targeting non protein structures of new coronavirus, such as papain like protease Prote ASE, RNA dependent RNA polymerase (RdRp) and other drugs targeting at ACE2, blocking the entry of new coronavirus into host cells, also including the control methods for post infection complications According to Meibo medical health, at present, there are first-line clinical experts (including Professor Cao Bin, who presides over the clinical trial of radcivir in the national medical team of Hubei assistance), experts in the molecular room of the clinical examination center of the National Health Commission, Professor of pharmacy of Xiangya Second Hospital, chief scientist of NASDAQ listed company, and scientists of international pharmaceutical companies (BMS) engaged in the research and development of viral drugs, Gilead, et al.), scientists from domestic listed pharmaceutical companies, scientists from Chairman of domestic innovative pharmaceutical companies, experts from Jiangsu pharmaceutical research and Development Association, and data model prediction experts from Shaanxi Normal University participated in the review of the project In order to promote the docking of overseas related projects with domestic scientific research teams and enterprises as soon as possible, Meibai healthcare is still recruiting experts and volunteers to conduct a second review of the projects In spite of the large gap, mayberhealth will strictly evaluate the candidates from the aspects of major and education background, work unit and position, working years and areas of expertise According to Meibo, pharmaceutical scientists, clinicians and experts in related fields are still in urgent need The epidemic situation is urgent We work overtime to two or three o'clock every day China and the United States work two shifts seamlessly, which has become the recent normal for medical and health people in Mabai Since the time of returning to work has been delayed again and again, the medical staff of Meibai gradually realized the seriousness of the epidemic in Wuhan "Since most of our teams are overseas, we didn't decide to launch this project until we found that the coordination and docking of materials is still a drop in the bucket." Meibai Medical Health said to yiou health In fact, it's both unexpected and reasonable for mabujian to join in the search for available drugs Like many enterprises, mayberhealth initially chose to use its overseas resources to connect with domestic materials However, due to the long period of purchasing materials overseas, the high price and many restrictions, mayber healthcare decided to return to the essence after a busy week At that time, the search for new coronavirus drugs in China was also in full swing, and the reports of various drugs entering clinical trials were overwhelming, and mabujian felt that it should really take advantage of its own advantages Tianyancha and Meibai medical health official website show that Meibai medical health was established in November 2016, focusing on the introduction and docking of medical devices, digital medicine, diagnostic technology, innovative drugs, precision medicine, gene detection, medical AR / VR and other fields of overseas high-quality innovation projects At present, Meibai healthcare mainly organizes China focus and Meibai healthcare global biomedical innovation and entrepreneurship competition and cubio innovation center established in Texas Medical Center (Houston city) in the United States to find, connect, incubate and introduce innovative technology projects and innovative talents with significant scientific and technological content for Chinese investors and government parks Novel coronavirus pneumonia, which has been awarded three new year's projects in the United States, Europe and Australia, has attracted more than 130 new drugs, therapeutics and medical devices from more than 250 countries, including overseas, approved, COVID-19, and clinical stages 24 But for the new coronavirus, a brand-new field, mayber healthcare is also a beginner It confessed to EUROHEALTH: "we hope to play a good role as a bridge, let the overseas advanced technology connect with domestic resources as soon as possible, and help Chinese patients and enterprises to apply it to the front line of the epidemic as soon as possible I also hope that more experts and insiders can participate in this event " Summary of the novel coronavirus pneumonia project: